<?xml version="1.0" encoding="UTF-8"?>
<ref id="B14">
 <label>14</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Cercek</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>Boerner</surname>
    <given-names>T</given-names>
   </name>
   <name>
    <surname>Tan</surname>
    <given-names>BR</given-names>
   </name>
   <name>
    <surname>Chou</surname>
    <given-names>JF</given-names>
   </name>
   <name>
    <surname>Gonen</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Boucher</surname>
    <given-names>TM</given-names>
   </name>
   <etal/>
  </person-group>. 
  <article-title>Assessment of Hepatic Arterial Infusion of Floxuridine in Combination With Systemic Gemcitabine and Oxaliplatin in Patients With Unresectable Intrahepatic Cholangiocarcinoma: A Phase 2 Clinical Trial</article-title>. 
  <source>JAMA Oncol</source> (
  <year>2019</year>) 
  <volume>6</volume>(
  <issue>1</issue>):
  <page-range>60–7</page-range>.  
  <pub-id pub-id-type="doi">10.1001/jamaoncol.2019.3718</pub-id>
 </mixed-citation>
</ref>
